Search Count: 50
All
Selected
 |
Organism: Influenza a virus, Aequorea victoria
Method: ELECTRON MICROSCOPY Release Date: 2025-08-13 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Influenza a virus
Method: ELECTRON MICROSCOPY Release Date: 2025-08-13 Classification: VIRAL PROTEIN |
 |
Organism: Influenza a virus
Method: ELECTRON MICROSCOPY Release Date: 2025-08-13 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Influenza a virus (strain a/hong kong/1/1968 h3n2), Aequorea victoria
Method: ELECTRON MICROSCOPY Release Date: 2025-08-06 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Influenza a virus (strain a/hong kong/1/1968 h3n2), Aequorea victoria
Method: ELECTRON MICROSCOPY Release Date: 2025-08-06 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-11-27 Classification: OXIDOREDUCTASE Ligands: IMP, VOA, SO4 |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-11-27 Classification: OXIDOREDUCTASE Ligands: IMP, A1A3K |
 |
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2023-10-11 Classification: HYDROLASE Ligands: SO4, YR2 |
 |
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2023-10-11 Classification: HYDROLASE Ligands: SO4, YT2 |
 |
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2023-10-11 Classification: HYDROLASE Ligands: ZH5 |
 |
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2023-10-11 Classification: HYDROLASE/INHIBITOR Ligands: ZJX |
 |
Vaccine Elicited Antibody Mu89 Bound To Ch848.D949.10.17_N133D_N138T.Ds.Sosip.664 Hiv-1 Env Trimer
Organism: Human immunodeficiency virus 1, Human immunodeficiency virus, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2023-04-19 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Vaccine Elicited Antibody Mu89+S27Y Bound To Ch848.D949.10.17_N133D_N138T.Ds.Sosip.664 Hiv-1 Env Trimer
Organism: Human immunodeficiency virus 1, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2023-04-19 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Bg505 Sosip.V5.2 In Complex With The Monoclonal Antibody Rh4O9.8 (As Fab Fragment)
Organism: Human immunodeficiency virus 1, Macaca mulatta
Method: ELECTRON MICROSCOPY Release Date: 2022-01-26 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Bg505 Sosip Md39 In Complex With The Monoclonal Antibodies Rh.33104 Mab.1 And Rm20A3
Organism: Macaca mulatta, Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Release Date: 2022-01-26 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Bg505 Sosip.V5.2(7S) In Complex With The Monoclonal Antibodies Rh.33172 Mab.1 And Rm19R
Organism: Macaca mulatta, Human immunodeficiency virus
Method: ELECTRON MICROSCOPY Release Date: 2022-01-26 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Macaca mulatta
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2020-09-16 Classification: IMMUNE SYSTEM Ligands: GLY |
 |
Organism: Macaca mulatta
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2020-09-16 Classification: IMMUNE SYSTEM Ligands: TAM, 2PE, P6G, PE8 |
 |
Organism: Macaca mulatta
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2020-09-16 Classification: IMMUNE SYSTEM Ligands: SO4 |
 |
Organism: Human immunodeficiency virus 1, Macaca mulatta
Method: ELECTRON MICROSCOPY Release Date: 2020-07-01 Classification: VIRAL PROTEIN Ligands: NAG |